PT Indofarma Tbk (IDX:INAF)

Market Cap	390.51B -81.2%
Revenue (ttm)	206.24B -4.4%
Net Income	-295.10B
EPS	-95.22
Shares Out	3.10B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,900
Average Volume	65,400
Open	126.00
Previous Close	126.00
Day's Range	126.00 - 126.00
52-Week Range	126.00 - 725.00
Beta	0.39
RSI	24.56
Earnings Date	Apr 30, 2026

About PT Indofarma Tbk

PT Indofarma Tbk, together with its subsidiaries, manufactures and sells pharmaceutical products in Indonesia and internationally. The company offers laboratory, pharmaceutical, and health glass equipment; orthopedic and prosthetic equipment; medical and dental equipment; and reparation of Irradiation / X-ray, electromedical and electrotherapy equipment. It also trades in laboratory, pharmaceutical, and medical equipment; and engages in herb infusion, health support, private polyclinic, general practitioner, dentist, and internet trading applic...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1918
• Employees: 21
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: INAF

Financial Performance

In 2024, PT Indofarma Tbk's revenue was 210.38 billion, a decrease of -59.82% compared to the previous year's 523.60 billion. Losses were -334.49 billion, -53.61% less than in 2023.